“seres-therapeutics” Archives

in
Entry Author Date Location
Finch Therapeutics Fetches $90M to Advance Microbiome Drug Pipeline 09/17/20 Boston
Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs 09/02/20 Seattle
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
Seres Sets Sights on FDA After C. Diff Microbiome Therapy Scores in Phase 3 08/10/20 Boston
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
In Microbiome Milestone, Finch Therapeutics C. diff Pill Bests Placebo 06/19/20 Boston
Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs 05/29/20 Boston
Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19) 04/22/20 National
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy 01/08/20 San Francisco
With Yale Tech and $12M, Artizan Aims for Root Cause of Gut Disease 06/10/19 Boston
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes 05/30/19 San Francisco
Flagship Pioneering Unveils Kintai’s Gut Approach to Treating Disease 04/16/19 Boston
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Kaleido Bio Downsizes IPO, Raises $75M for Microbiome Drug Tests 02/27/19 Boston
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More 02/08/19 National
Seres Lays Off 30% of Staff, CSO Leaves After Pipeline Review 02/07/19 Boston
Microbiome Startup uBiome Expands into Drug Research with $83M 09/21/18 San Francisco
Trump v. Drug Makers? And 6 More Burning Biopharma Questions for 2018 01/02/18 National
Flagship Bags $618M, Its Largest Raise Ever, For a New Startup Crop 12/20/17 Boston
Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More 10/06/17 National
Ex-Cubist CEO Bonney Emerges at Kaleido, Flagship’s Latest Microbiome Startup 09/18/17 Boston
Akili, Emulate, Ginkgo & More: The Innovation at the Intersection Award Finalists 09/18/17 Boston
Dealmaker, Thought Leader & More: The X of the Year Xconomy Award Finalists 09/15/17 Boston
Evelo Bio Raises $50M Round to Bring Microbiome Drugs Into Trials 07/11/17 Boston
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
Bio Roundup: Trump Budget, FDA Chief, CAR-T Qs, CRISPR Cash, & More 03/17/17 National
With FDA’s Blessing, Seres Preps New “Pivotal” Microbiome Drug Trial 03/16/17 Boston
FDA Turmoil, Biology Mystery On List Of Hurdles For Microbiome Drugs 02/14/17 New York
Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins 02/03/17 National
Page 1 of 2 next page »